SPECIFIC IMMUNOTHERAPY FOR ALLERGIC RHINITIS IN ITALY: THE DOCTORS' POINTS OF VIEW

被引:2
作者
Larosa, M. [1 ]
Ciprandi, G. [2 ]
Tesi, C. F. [3 ]
Cadario, G. [4 ]
Fiocchi, A. [5 ]
Frati, F. [6 ]
Romano, A. [7 ]
机构
[1] Univ Catania, Catania, Italy
[2] Univ San Martino, Azienda Osped, Dipartimento Med Interna, Genoa, Italy
[3] Italian Asthmat Patients Federat, Turin, Italy
[4] Azienda Osped Molinette, Catania, Italy
[5] Azienda Osped Macedonio Melloni, Milan, Italy
[6] Stallergenes Italy, Milan, Italy
[7] Catholic Univ, Rome, Italy
关键词
allergic rhinitis; specific immunotherapy; doctors; prescription; educational level;
D O I
10.1177/039463200902200130
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Specific immunotherapy (SIT) is the unique causal treatment for allergy, but its prescription is quite restricted. A perspective and cross-sectional survey based on telephone interviews was carried out in Italy to evaluate the profile of doctors prescribing SIT for allergic rhinitis. A total of 540 doctors were interviewed, 200 of whom are GPs, 60 allergists, 60 ENT specialists, 100 familial paediatricians, 60 hospital paediatricians and 60 pulmonologists. Significant differences concern diagnostic and therapeutic management of allergic rhinitis, mainly regarding SIT prescription. The allergist is the most important consultant who prescribes SIT, as opposed to the paediatrician. This study therefore provides the evidence that doctors' behaviour towards SIT depends on the type of graduate studies.
引用
收藏
页码:251 / 254
页数:4
相关论文
共 50 条
  • [31] Outcome of Sublingual Immunotherapy in Allergic Rhinitis
    Debajyoti Das
    Santanu Sit
    Ajoy Kumar Khaowas
    Chiranjib Das
    Dwaipayan Mukherjee
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2021, 73 : 467 - 473
  • [32] HLA-II genes are associated with outcomes of specific immunotherapy for allergic rhinitis
    Zhao, Yanming
    Zhao, Yali
    Zhang, Yuan
    Zhang, Luo
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2019, 9 (11) : 1311 - 1317
  • [33] Immunotherapy with allergen extracts for allergic rhinitis
    Riechelmann H.
    HNO, 2005, 53 (6) : 517 - 530
  • [34] Allergen-specific immunotherapy for allergic rhinitis in the elderly: is it never too late?
    Milani, Massimo
    IMMUNOTHERAPY, 2013, 5 (07) : 699 - 702
  • [35] Efficacy of subcutaneous specific immunotherapy for allergic rhinitis combined with asthma: a retrospective analysis
    Hao, Qing
    Chen, Zhenghong
    Yin, Yiping
    Cao, Ye
    Deng, Jikun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (10): : 5933 - 5942
  • [36] Economic Evaluation of Specific Immunotherapy Versus Symptomatic Treatment of Allergic Rhinitis in Germany
    Peter K. Schädlich
    Josef G. Brecht
    PharmacoEconomics, 2000, 17 : 37 - 52
  • [37] Mechanisms of Allergen Immunotherapy in Allergic Rhinitis
    Drazdauskaite, Gabija
    Layhadi, Janice A.
    Shamji, Mohamed H.
    CURRENT ALLERGY AND ASTHMA REPORTS, 2021, 21 (01)
  • [38] Subcutaneous Allergen-Specific Immunotherapy Is Safe in Pediatric Patients with Allergic Rhinitis
    Pavon-Romero, Gandhi F.
    Larenas-Linnemann, Desiree E.
    Xochipa Ruiz, Karen Eloisa
    Ramirez-Jimenez, Fernando
    Teran, Luis M.
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2021, 182 (06) : 553 - 561
  • [39] The impact of allergen exposure and specific immunotherapy on circulating blood cells in allergic rhinitis
    Jordakieva, Galateja
    Jensen-Jarolim, Erika
    WORLD ALLERGY ORGANIZATION JOURNAL, 2018, 11
  • [40] Prevalence and features of allergic rhinitis in Italy
    Olivieri, M
    Verlato, G
    Corsico, A
    Lo Cascio, V
    Bugiani, M
    Marinoni, A
    de Marco, R
    ALLERGY, 2002, 57 (07) : 600 - 606